Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.
暂无分享,去创建一个
M. Laakso | M. Laakso | S. Haffner | K. Pyörälä | S. Lehto | T. Rönnemaa | K. Pyörälä
[1] D. Cox. Regression Models and Life-Tables , 1972 .
[2] D L McGee,et al. Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study , 1979, Diabetes Care.
[3] F. D. Weinfeld,et al. The National Survey of Stroke. Clinical findings. , 1981, Stroke.
[4] M. Laakso,et al. Diabetes and atherosclerosis: an epidemiologic view. , 1987, Diabetes/metabolism reviews.
[5] P. Wilson,et al. The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study. , 1988, JAMA.
[6] M. Laakso,et al. Atherosclerotic Vascular Disease and Its Risk Factors in Non-Insulin-Dependent Diabetic and Nondiabetic Subjects in Finland , 1988, Diabetes Care.
[7] L. Wilhelmsen,et al. Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study. , 1989, BMJ.
[8] J Pekkanen,et al. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. , 1990, The New England journal of medicine.
[9] J. Herlitz,et al. Prognosis in diabetics with chest pain or other symptoms suggestive of acute myocardial infarction. , 1992, Cardiology.
[10] J. Neaton,et al. Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.
[11] H. Tunstall-Pedoe,et al. Myocardial Infarction and Coronary Deaths in the World Health Organization MONICA Project: Registration Procedures, Event Rates, and Case‐Fatality Rates in 38 Populations From 21 Countries in Four Continents , 1994, Circulation.
[12] B. Davis,et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.
[13] Terje R Pedersen,et al. Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) , 1997, Diabetes Care.
[14] L. Wilhelmsen,et al. Serum cholesterol and long-term prognosis in middle-aged men with myocardial infarction and angina pectoris. A 16-year follow-up of the Primary Prevention Study in Göteborg, Sweden. , 1997, European heart journal.
[15] M. Laakso,et al. Dyslipidemia and Hyperglycemia Predict Coronary Heart Disease Events in Middle-Aged Patients With NIDDM , 1997, Diabetes.
[16] S. Haffner. The Scandinavian Simvastatin Survival Study (4S) Subgroup Analysis of Diabetic Subjects: Implications for the Prevention of Coronary Heart Disease , 1997, Diabetes Care.
[17] V. Salomaa,et al. Impact of Diabetes on Mortality After the First Myocardial Infarction , 1998, Diabetes Care.
[18] S. Haffner. Management of Dyslipidemia in Adults With Diabetes , 1998, Diabetes Care.